Джейн Плант - Ваша жизнь в ваших руках. Как понять, победить и предотвратить рак груди и яичников

39. Holly, Jeff, 1998. Insulin-like growth factor-1 and new opportunities for cancer prevention. Lancet, 351, 9113, 9 May, 1373–1375.

40. Epstein, Samuel S., 1996. Unlabelled Milk from Cows Treated with Biosynthetic Growth Hormones: A Case of Regulatory Abdication. International Journal of Health Services, 26, 1, 173–185.

41. Outwater, J. L., Nicholson A. and Bernard N., 1997. Dairy products and breast cancer: the IGF-1, estrogen, and bGH hypothesis. Medical Hypotheses 48, 453–461.

42. Leonard, Rodney E., 1995. Codex at the Crossroads: Conflict on Trade Health. Nutrition Week, Vol. 25, № 26, 14 July, pp. 4–5, Nutrition Week is published by the Community Nutrition Institute, 910 17th Street, N.W, Suite 413, Washington DC 20006.

43. The European Commission. Health and Consumer Protection. Scientific Committee on Veterinary Measures relating 10 Public Health – Outcome of discussions, http://europa.eu. mt/comm/dg24/health/ sc/scv/ out 19_en.html

44. D’Ercole, J.A., Underwood, L.E. and Van Wyk, J.J., 1977. Serum Somatomedin-C in hypopituaritism and in other disorders of growth./. Pediatr, 90, 3, 375–381. See also Cullen, K.J. and others, 1990. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Research, vol. 50, pp. 48–53.

45. De Leon, D.D., Wilson, D.M., Powers, M. and Rosenfeld, R.G., 1992. Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells. Growth Factors, 6, 327–336.

46. Peyrat, J.P., Bonneterre, J. and Hecquet, B. and others, 1993. Plasma insulin-like growth factor 1 (IGF-1) concentrations in human breast cancer. Eur J Cancer, 29A, 4, 492–497.

47. Peyrat, J.P., Bonneterre, J. and Hecquet, B. and others, 1993. Plasma insulin-like growth factor 1 (IGF-1) concentrations in human breast cancer. Eur J Cancer, 29A, 4, 492–497.

48. Musgrove, E.A. and Sutherland, R.I., 1993. Acute effects of growth factors on T471 breast cancer cell cycle progression, Eur J Cancer, 29 A, 16, 2273–2279.

49. Heldrin, C.N. and Westermark, B., 1984. Growth factors: mechanism of action and relation to oncogenes. Cell, 37:9, 20.

50. Macaulay, V. М., 1992. Insulin-like growth factors and cancer. Br J Cancer, 65, 311–320.

51. Underwood, L.E., D’Ercole, J.A. and Van Wyk, J.J., 1980. So-matomedin-C and the assessment of growth. Fed ClinN Amer,

27, 4, 771–782, and Perdue, J.F., 1984. Chemistry, structure and function of insulin-like growth factors and their receptors: a review. Can J Biochem Cell Bio., 62, 1237–1245.

52. Outwater, J.L., Nicholson, A, and Barnard, N., 1997. Dairy products and breast cancer; the IGF-1 estrogen, and bGH hypothesis. Medical Hypotheses, 48, 453–461.

53. The European Commission. Health and Consumer Protection. Scientific Committee on Veterinary Measures relating 10 Public Health – Outcome of discussions. http://europa.eu.int/comm/dg24/health/ sc/scv/ outl 9_en.html

54. Council on Scientific Affairs, American Medical Association, Biotechnology and the American Agricultural Industry, 1991. Journal of the American Medical Association (JAMA), 265, 11, 20 March, p. 1433.

55. Mepham, T.B. and Schonfield, P.N., 1995. Health Aspects of BST Milk, prepared for the International Dairy Federation Nutrition Week conference in Paris, France, June 1995.

56. Challacombe. D.N. and Wheeler, E.E., 1994. Safety of milk from cows treated with bovine somatotropin. Lancet, 344, 17 September, p. 815.

57. Sell, C., Rubin, R. and Baserga, R., 1995. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-in-duced apoptosis. Cancer Research, Jan 15, 55(2), 303–306.

58. Burton, Jeanne L. and others, 1994. A review of bovine growth hormone, Canadian Journal of Animal Science, 74, 167–201.

59. Xian, C., 1995. Degradation of IGF-1 in the Adult Rat Gastrointestinal Tract is limited by a Specific Antiserum of the Dietary Protein Casein .Journal of Endocrinology, 146, 2, 1 August, p. 215, and Thornburg, W and others, 1984. Gastrointestinal absorption of epidermal growth factor in suckling rats. American Journal of Physiology, 246, G80-G85.

60. Outwater, J.L., Nicholson, A. and Barnard, N., 1997. Dairy products and breast cancer; the IGF-1 estrogen, and bGH hypothesis. Medical Hypotheses, 48, 453–461.

61. Harasuchi, S., Good, R.A., Engelman, R.W and Day, N.K., 1992. Human prolactin regulates transfected MMTV LTR-di-rected gene expression in a human breast-carcinoma cell line through synergistic interaction with steroid hormones. Int J Cancer, 52, 923–933.

62. Clevenger, C,V, Chang, WF., Ngo, W, Pasha, T.L., Montone, K.T. And Tomaszewski, J. E., 1995. Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop .Am J Pathol, 146, 695–705.

63. Vonderhaar B.K., 1989. Estrogens are not required for prolactin induced growth of MCF-7 human breast cancer cells. Cancer Lett, A7, 105–110.

64. http://www.shef.ac.uk/uni/academic/a-c/csi/1997/pir2.html

65. Lochnan, H.A. and others, 1995. Functional activity of the human prolactin receptor and its ligands. Mol. Cell. Endocrinol, 114, 91–99.

66. http://mammary.nih.20v/reviews/tumorigenesis/Vonderhaar 001/ slides/introduction.html

67. Struman, I., Bentzien, F., Lee, H., Mainfroid, V, D’Angelo, G., Goffin, V., Weiner, R.I. and Martial, J.A., 1999. Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sei USA, 96, 1246–1251.

68. http://www.eurekalert.org/releases/upmc-bcc061699.html

69. Lawrence R., 1994. Breastfeeding – A Guide to the Medical Profession, Fourth edition, Mossby, USA.

70. http://www.inter-medico.com/prolactin.html

71. Lawrence, R., 1994. Breastfeeding: A Guide for the Medical Profession. Fourth edition, Mossby, USA.

72. Poggi, S.H., Skinner, H., Catherine W and others, 1998. Using scanning electron microscopy to study mineral deposits in breast tissues. American Mineralogist, 83, 1122–1126.

73. Lee, J.R., 1996. Natural Progesterone. John Carpenter Publishing, Oxfordshire, 113 pp.

74. Wolford, S.T. and Argoudelis, C.J., 1979. Measurement of Estrogens in Cow’s Milk, Human Milk and Dairy Products. /. Dairy Sei., 62(9), 1458–1463.

75. Outwater, J.L., Nicholson, A. and Barnard, N., 1997. Dairy products and breast cancer; the IGF-1 estrogen, and bGH hypothesis. Medical Hypotheses, 48, 453–461.

76. The European Commission. Health and Consumer Protection. Scientific Committee on Veterinary Measures relating to Public Health – Outcome of discussions. 1999, Report on Public Health Aspects of the Use of Bovine Somarotropin. http://europa.eu.int/com m/d g2 4/health/s c/s cv/outl9_ en.html

77. Allen, N.E., and others, 2000. Hormones and Diet: Low Insulin-like Growth Factor-1 but Normal Bioavailable Androgens in Vegan Men. Brit. J. Cane., 83 (1), 95–97.

78. Chan, J.C., and others, 1998. Plasma TGF-1 and Prostate Cancer Risk: A Prospective Study. Science 279, January.

79. Kradjian, R.D., 1994. Save Yourself from Breast Cancer, Berkley Books, New York.

1. Wright, K., 1996. A plea for prevention. Scientific American, September. (Inset p.99 in article by Greenwald 1996, see below ref. 20).

2. Collaborative Group on Hormonal Factors in Breast Cancer, 1996. Lancet, 347, 1713–1727.

3. http://www.who.int/nut/malnutrition_worldwide.html

4. The Times, 2 November 1999.

5. Riggs, B.L., Wahner, H.W, Melton, L.J. 3rd, Richelson, L.S., Judd, H.L. And O’Fallon, WM., 1987. Dietary calcium intake and rates of bone loss in women. / Clin Invest, Oct, 80, 4, pp. 979–982.

6. Hegsted, D.M., 1986. Calcium and Osteoporosis./Nutr, 116, 2316–2319.

7. Kim, J.B., 1990. Fractured truths. Bestways vl8, n2, p26(7).

8. Kim, J.B., 1990. Fractured truths. Bestways vl8, n2, p26(7).

9. http://www.who.int/nut/malnutrition_worldwide.html

10. Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. Department of Health, 1991.

11. Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. Department of Health, 1991. P. 139, table 22.2.

12. Havaia, S. and Dwyer, J., 1988. Position of the American Dietetic Association: Vegetarian Diets – technical support pa-per .J Am Diet Assoc, 88:3 352–355.

13. Barnard, N., 1993. Food for life, Harmony Books.

14. ‘Research Advances in Osteoporosis’, 1990. Conference by the National Osteoporosis Foundation, the National Institutes of Health, and the American Society of Bone and Mineral Research, Arlington, Virginia, USA February.

15. Heaney, R.P. and Weaver, C.M., 1990. Calcium absorbability from kale.^LwJ Clin Nutr, 51, 656–657.

16. Breslau, N.A., Brinkley, L., Hill, K.D. and Pak, C.Y., 1988. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism./ Clin EndocrinolMetah, Jan, 66,

1, pp. 140–146.

17. Heaney, R.P. and Recker, R.R., 1982. Effects of nitrogen, phosphorus, and caffeine on calcium balance in women. J Lab Clin Mod, Jan, 99, 1, pp. 46–55.

18. Pritchard, K.I. and others, 1996. Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer, Journal of Clinical Oncology, vol. 14 (10), 2731–2738.

19. Gooderham, M.J., Adlercreutz, H., Sirpa, T.O., Wahala, K. and Holub, B.J., 1996. A Soy Protein Isolate Rich in Genistein and Daidzein and its Effects on Plasma Isoflavone Concentrations, Platelet Aggregation, Blood Lipids and Fatty Acid Composition of Plasma Phospholipid in Normal Men. J. Nutr., 126, 2000–2006.

20. Greenwald, Peter, 1996. Chemoprevention of Cancer. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 96–99.

21. Kurzer, M.S. and Xu, X., 1999. Dietary Phytoestrogens. Annual Reviews of Nutrition, Vol. 17, pp. 353–381.

22. Shurtleff, William and Aoyagi, Akiko, 1975. The Book: of Tofu. Autumn Press Inc.

23. Kurzer, M.S. and Xu, X., 1999, Dietary Phytoestrogens. Annual Reviews of Nutrition Vol. 17, pp. 353–381.

24. UK Ministry of Agriculture, Fisheries and Food advice as reported in the Sunday Times, 1999.

25. Willet WC., 1994. Micronutrients and cancer risk. Am J Clin Nutr, 59, (suppl), 1162S-5S. See also: Willett, Walter C., Colditz, Graham A. and Mueller, Nancy A., 1996, Strategies for Minimising Cancer Risk. Scientific American, Special Issue, «What you need to know about Cancer, September», 275, 3, 88–95.

26. Greenwald, Peter, 1996. Chemoprevention of Cancer. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 96–99.

27. Levy, J., Bosin, E., Feldman, B., Giat, Y., Milnster, Danilenko, M. and Sharoni, Y, 1995. Lycopene is more potent inhibitor of human cancer cell proliferation than either A-carotene or B-carotene. Nutr Cancer, 24, 257–266.

28. Nagasawa, H., Mitamura, Т., Sakamoto, S, and Yamamoto, K., 1995. Effects of lycopene on spontaneous mammary tumour development in SHN virgin mice. Anticancer Res. 15, 1173–1178.

29. Willett, Walter C., Colditz, Graham A. and Mueller, Nancy A., 1996. Strategies for Minimising Cancer Risk. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 88–95.

30. Ortega, R.M. and others, 1996. Functional and Psychic Deterioration in Elderly People may be aggravated by folate deficiency. / Nutr., 126, 1992–1999.

31. Phipps, WR., Martini, M.C., Lampe, J.W, Slavin, J.L. and Kurzer, M.S., 1993. Effect of flax seed ingestion on the menstrual cycle./ Clin EndocrinolMetab., 77, 5, November, 1215–1219.

32. www.flax.com.fda

33. Greenwald, Peter, 1996. Chemoprevention of Cancer. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 96–99.

34. Coghlan, Andy, 1999. Crunch Time for Cancer. New Scientist, 13 November, 264, 2212.

35. Pinto, J.T., Qiao, C.H., Xing, J., Rivlin, R.S., Protomastro, M.L., Weissler, M.L. and Hesion, WD.W, 1999. Effects of garlic thioallylic derivatives on growth, glutathione concentration, and polyamine formation of human prostate carcinoma cells in culture. Am. J. Clin. Nutr. See also: Li, G., Qiao, C.H., Lin, R.I., Pinto, J., Osborne, M.F., and Tiwari, R.K., 1995, Antiproliferative effects of garlic constituents in cultured human breast cancer cells. Oncology Rpts., 2, 787–791.

36. www.3mistral.co.uk/garlic/cancer.htm;www.mskcc.org/rande/ pharmacology/189.html

37. Greenwald, Peter, 1996. Chemoprevention of Cancer. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 96–99.

38. Doll, R. and Peto, R., 1981. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. New York: Oxford University Press.

39. Lang, T. and Clutterbuck, C., 1991. P is for Pesticides, Ebury Press, Random Century Group, 256p.

40. McMichael, A.J., 1993. Planetary Overload – Global Environmental Change and the Health of the Species. Cambridge University Press.

41. Lang, T. and Clutterbuck, C., 1991. P is for Pesticides, Ebury Press, Random Century Group, 256p.

42. http://www.radian.com/standards; http://ro-systemsnet/atra-zine.html

43. Stevens and others, 1994. http://www-oem.ucdavis.edu~beaumont/Agrichem/herbi-cides/triazine/triazine.html

Stevens, J.T. and Sumner, D.D., 1991. Herbicides, in Handbook of Pesticide Toxicology3 Vol. 3. Classes of Pesticides, Toronto: Academic Press Inc, 1317–1408. See also Environmental Endocrine Disrupters: A handbook of property data, 1999.

44. http://who-pcc.iarc.fr/

45. Hambridge, K. M., Casey, C. E. and Krebs, N. E, 1986, Zinc, In: Trace Elements in Human and Animal Nutrition, Fifth Edition, Mertz, W, Ed. Academic Press, Inc, London.